http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-108482-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d78cd2835221849f6a74e6349185819
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 1992-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb2cfaa130a95b8b43e6cdbdfcf859b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eeeaa0423da7f2d1cc9c99979cf3073
publicationDate 1996-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-108482-A
titleOfInvention Compounds.
abstract THE PRESENT INVENTION RELATES TO PYRIDAZINO [4, 5-B] QUINOLINES,(FORMULA 1)AND PHARMACEUTICALLY USEFUL SALTS THEREOF, WHICH ARE EXCITATORY AMINO ACID ANTAGONISTS AND WHICH ARE USEFUL WHEN SUCH ANTAGONISM IS DESIRED SUCH AS IN THE TREATMENT OF NEUROLOGICAL DISORDERS. THE INVENTION FURTHER PROVIDES PHARMACEUTICAL COMPOSITIONS CONTAINING PYRIDAZINO [4, 5-B] QUINOLINES AS ACTIVE INGREDIENT, AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS.
priorityDate 1991-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424983022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047

Total number of triples: 34.